Our findings that FAP is expressed on the NK cell surface suggests that anti-FAP/IL-2 fusion protein may also target IL-2 directly to NK cells, enhancing NK cell activation and potentially tumor clearance. The gene discussed is IL2; the disease is neoplasm.